Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Universidade de São Paulo (USP) | - |
Autor(es): dc.creator | Di Filippo, Leonardo Delello [UNESP] | - |
Autor(es): dc.creator | Duarte, Jonatas Lobato [UNESP] | - |
Autor(es): dc.creator | Luiz, Marcela Tavares | - |
Autor(es): dc.creator | de Araújo, Jennifer Thayanne Cavalcante [UNESP] | - |
Autor(es): dc.creator | Chorilli, Marlus [UNESP] | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:54:16Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:54:16Z | - |
Data de envio: dc.date.issued | 2021-06-25 | - |
Data de envio: dc.date.issued | 2021-06-25 | - |
Data de envio: dc.date.issued | 2020-12-31 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.2174/1570159X18666200831160627 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/208730 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/208730 | - |
Descrição: dc.description | Glioblastoma multiforme (GBM) is the most common primary malignant Central Nervous System cancer, responsible for about 4% of all deaths associated with neoplasia, characterized as one of the fatal human cancers. Tumor resection does not possess curative character, thereby radio and/or chemotherapy are often necessary for the treatment of GBM. However, drugs used in GBM chemotherapy present some limitations, such as side effects associated with non-specific drug biodistribution as well as limited bioavailability, which limits their clinical use. To attenuate the systemic toxicity and overcome the poor bioavailability, a very attractive approach is drug encapsulation in drug delivery nanosystems. The main focus of this review is to explore the actual cancer global problem, enunciate barriers to overcome in the pharmacological treatment of GBM, as well as the most updated drug delivery nanosystems for GBM treatment and how they influence biopharmaceutical properties of anti-GBM drugs. The discussion will approach lipid-based and polymeric nanosystems, as well as inorganic nanoparticles, regarding their technical aspects as well as biological effects in GBM treatment. Furthermore, the current state of the art, challenges to overcome and future perspectives in GBM treatment will be discussed. | - |
Descrição: dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | - |
Descrição: dc.description | School of Pharmaceutical Sciences São Paulo State University (UNESP) | - |
Descrição: dc.description | School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo (USP) | - |
Descrição: dc.description | School of Pharmaceutical Sciences São Paulo State University (UNESP) | - |
Descrição: dc.description | FAPESP: 2018/ 18488-3 | - |
Formato: dc.format | 787-812 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Current Neuropharmacology | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Brain cancer | - |
Palavras-chave: dc.subject | Cancer therapy | - |
Palavras-chave: dc.subject | Inorganic nanoparticles | - |
Palavras-chave: dc.subject | Lipid-based systems | - |
Palavras-chave: dc.subject | Pharmaceutical nanotechnology | - |
Palavras-chave: dc.subject | Polymeric systems | - |
Título: dc.title | Drug delivery nanosystems in glioblastoma multiforme treatment: Current state of the art | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: